![Multi-omic serum biomarkers for prognosis of disease progression in prostate cancer | Journal of Translational Medicine | Full Text Multi-omic serum biomarkers for prognosis of disease progression in prostate cancer | Journal of Translational Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12967-019-02185-y/MediaObjects/12967_2019_2185_Fig1_HTML.png)
Multi-omic serum biomarkers for prognosis of disease progression in prostate cancer | Journal of Translational Medicine | Full Text
![Diagnostic potential in prostate cancer of a panel of urinary molecular tumor markers. | Semantic Scholar Diagnostic potential in prostate cancer of a panel of urinary molecular tumor markers. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1ba87ca92c0a56d3ea3f7c02a9d1191263a1b92a/5-Table3-1.png)
Diagnostic potential in prostate cancer of a panel of urinary molecular tumor markers. | Semantic Scholar
![Prostate-specific markers to identify rare prostate cancer cells in liquid biopsies | Nature Reviews Urology Prostate-specific markers to identify rare prostate cancer cells in liquid biopsies | Nature Reviews Urology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41585-018-0119-5/MediaObjects/41585_2018_119_Fig1_HTML.png)
Prostate-specific markers to identify rare prostate cancer cells in liquid biopsies | Nature Reviews Urology
![Extracellular vesicles as a source of prostate cancer biomarkers in liquid biopsies: a decade of research | British Journal of Cancer Extracellular vesicles as a source of prostate cancer biomarkers in liquid biopsies: a decade of research | British Journal of Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41416-021-01610-8/MediaObjects/41416_2021_1610_Fig1_HTML.png)
Extracellular vesicles as a source of prostate cancer biomarkers in liquid biopsies: a decade of research | British Journal of Cancer
![New insights and options into the mechanisms and effects of combined targeted therapy and immunotherapy in prostate cancer: Molecular Therapy - Oncolytics New insights and options into the mechanisms and effects of combined targeted therapy and immunotherapy in prostate cancer: Molecular Therapy - Oncolytics](https://www.cell.com/cms/attachment/b36c7d0d-d39a-4a70-b3a4-9c3e7a4e576b/fx1_lrg.jpg)
New insights and options into the mechanisms and effects of combined targeted therapy and immunotherapy in prostate cancer: Molecular Therapy - Oncolytics
![Prostate-specific markers to identify rare prostate cancer cells in liquid biopsies | Nature Reviews Urology Prostate-specific markers to identify rare prostate cancer cells in liquid biopsies | Nature Reviews Urology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41585-018-0119-5/MediaObjects/41585_2018_119_Fig2_HTML.png)
Prostate-specific markers to identify rare prostate cancer cells in liquid biopsies | Nature Reviews Urology
![Improving the diagnosis of prostate cancer by telomerase-positive circulating tumor cells: A prospective pilot study - eClinicalMedicine Improving the diagnosis of prostate cancer by telomerase-positive circulating tumor cells: A prospective pilot study - eClinicalMedicine](https://www.thelancet.com/cms/attachment/8c017a26-d2d7-4bf7-8993-d2e5b28d9ff2/gr1_lrg.jpg)
Improving the diagnosis of prostate cancer by telomerase-positive circulating tumor cells: A prospective pilot study - eClinicalMedicine
![Prostate Specific Antigen as a Tumor Marker in Prostate Cancer: Biochemical and Clinical Aspects | SpringerLink Prostate Specific Antigen as a Tumor Marker in Prostate Cancer: Biochemical and Clinical Aspects | SpringerLink](https://media.springernature.com/lw685/springer-static/image/chp%3A10.1007%2F978-94-017-7215-0_7/MediaObjects/338384_1_En_7_Fig1_HTML.gif)